Cybin Inc
We’re on a mission to revolutionize mental healthcare
Toronto, Canada
73 employees
Post-IPO Equity
Total: $398.53M
Biotechnology, Health Care +2
General Information
Toronto, Canada
BounceWatch is an independent company data service, not affiliated with Cybin Inc. To contact Cybin Inc, visit cybin.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Canada Market
Biotechnology
About Cybin Inc
Taxonomy: biopharmaceutical, mental healthcare, drug discovery, psilocybin, DMT, psychiatric therapies, clinical-stage, pharmaceutical industry, medicine, neuroscience, mental health conditions, clinical trials, depressive disorder, anxiety disorder
Funding Rounds & Investors (10)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $150.00M | 8 |
|
13 Mar 2024 |
| Post IPO Equity | $30.00M | - |
|
10 Nov 2023 |
| Post IPO Equity | $8.25M | - |
|
01 Aug 2023 |
| Post IPO Equity | $41.00M | 1 |
|
30 May 2023 |
| Post IPO Equity | $34.50M | - |
|
27 Jul 2021 |
| Post IPO Equity | $34.30M | - |
|
18 Jan 2021 |
| Venture Round | $45.00M | - |
|
19 Oct 2020 |
| Series B | $45.00M | 7 |
|
01 Jul 2020 |
| Series A | $7.00M | - |
|
01 Apr 2020 |
| Seed Round | $3.48M | 1 |
|
01 Mar 2020 |
Cybin Inc Alternatives & Competitors
Relmada (Nasdaq: $RLMD) is a clinical-stage company developing novel therapies for the treatment of...
We make therapeutic games for mental well-being, supported by rigorous evidence.
Brain Health, Reimagined
FAQ About Cybin Inc
Source: BounceWatch company record for Cybin Inc, https://bouncewatch.com/company/cybin-inc, updated 9 June 2026. When citing, please name BounceWatch and link this page.
